CS/CS/CS/HB 1481: Sickle Cell Disease Medications, Treatment, and Screening
GENERAL BILL by Health & Human Services Committee ; Health Care Appropriations Subcommittee ; Healthcare Regulation Subcommittee ; Driskell ; Campbell ; (CO-INTRODUCERS) Amesty ; Bartleman ; Joseph ; Woodson
Sickle Cell Disease Medications, Treatment, and Screening; Requires certain health care providers to notify primary care physicians of newborns & infants of certain screening results relating to sickle cell hemoglobin variants & to submit such results to DOH for specified purpose; requires such physicians to provide certain information to parents & guardians; requires DOH to establish & maintain sickle cell registry; authorizes parents & guardians to request to have their children removed from registry; requires AHCA to review sickle cell disease medications, treatments, & services for Medicaid recipients & develop written report, post report on its website, & submit copy of report to Governor, Legislature, & certain entities. APPROPRIATION: $1,332,159
Last Action: 5/2/2023 House - Laid on Table; companion bill(s) passed, see CS/CS/SB 1352 (Ch. 2023-258)
Bill Text: PDF
-
Bill History
Date Chamber Action 3/6/2023 House • Filed
3/7/2023 House • 1st Reading (Original Filed Version)
3/9/2023 House • Referred to Healthcare Regulation Subcommittee
• Referred to Health Care Appropriations Subcommittee
• Referred to Health & Human Services Committee
• Now in Healthcare Regulation Subcommittee
3/20/2023 House • Added to Healthcare Regulation Subcommittee agenda
3/22/2023 House • Favorable with CS by Healthcare Regulation Subcommittee
3/24/2023 House • Reported out of Healthcare Regulation Subcommittee
• Laid on Table under Rule 7.18(a)
• CS Filed
• 1st Reading (Committee Substitute 1)
3/27/2023 House • Referred to Health Care Appropriations Subcommittee
• Referred to Health & Human Services Committee
• Now in Health Care Appropriations Subcommittee
4/10/2023 House • Added to Health Care Appropriations Subcommittee agenda
4/12/2023 House • Favorable with CS by Health Care Appropriations Subcommittee
• Reported out of Health Care Appropriations Subcommittee
4/13/2023 House • Laid on Table under Rule 7.18(a)
• CS Filed
• Referred to Health & Human Services Committee
• Now in Health & Human Services Committee
• Added to Health & Human Services Committee agenda
• 1st Reading (Committee Substitute 2)
4/17/2023 House • Removed from Meeting Agenda of Health & Human Services Committee
4/23/2023 House • Added to Health & Human Services Committee agenda
4/24/2023 House • Favorable with CS by Health & Human Services Committee
• Reported out of Health & Human Services Committee
4/25/2023 House • Laid on Table under Rule 7.18(a)
• CS Filed
• Bill referred to House Calendar
• 1st Reading (Committee Substitute 3)
• Added to Second Reading Calendar
5/2/2023 House • Laid on Table; companion bill(s) passed, see CS/CS/SB 1352 (Ch. 2023-258)
-
CS/CS/CS/HB 1481, Committee Substitute 3 (Current Bill Version) Posted 4/25/2023 at 8:55 AM
Bill Text: PDF Analyses: None Related Bills (1)
Bill Number Subject Filed By Relationship Last Action and Location Track Bills S 1352 (er) Sickle Cell Disease Medications, Treatment, and Screening Rouson Similar Last Action: 6/20/2023 Chapter No. 2023-258 
Citations - Statutes (2)
Citation Catchline Location in Bill Location In Bill Help 383.147 Page 2 (pdf) 409.91235 Page 3 (pdf) -
CS/CS/HB 1481, Committee Substitute 2 Posted 4/13/2023 at 8:46 AM
Bill Text: PDF Analyses: Health & Human Services Committee (Post-Meeting) 4/24/2023 (pdf)
Related Bills (1)
Bill Number Subject Filed By Relationship Last Action and Location Track Bills S 1352 (c2) Sickle Cell Disease Medications, Treatment, and Screening Rouson Similar Last Action: 6/20/2023 Chapter No. 2023-258
Committee Amendments (1)
Amendment Sponsor Filed Last Committee Action Format 475673 - Amendment
Remove lines 132-158 and insert:Woodson 4/24/2023
12:14 PMAdopted without Objection
4/24/2023PDF Citations - Statutes (2)
Citation Catchline Location in Bill Location In Bill Help 383.147 Page 2 (pdf) 409.91235 Page 3 (pdf) -
CS/HB 1481, Committee Substitute 1 Posted 3/24/2023 at 12:23 PM
Bill Text: PDF Analyses: Health Care Appropriations Subcommittee (Post-Meeting) 4/12/2023 (pdf)
Related Bills (1)
Bill Number Subject Filed By Relationship Last Action and Location Track Bills S 1352 Medicaid Enrollees with Sickle Cell Disease Rouson Compare Last Action: 6/20/2023 Chapter No. 2023-258
Committee Amendments (1)
Amendment Sponsor Filed Last Committee Action Format 865259 - Amendment
Between lines 158 and 159, insert:Driskell 4/11/2023
3:44 PMAdopted without Objection
4/12/2023PDF Citations - Statutes (2)
Citation Catchline Location in Bill Location In Bill Help 383.147 Page 2 (pdf) 409.91235 Page 3 (pdf) -
HB 1481, Original Filed Version Posted 3/6/2023 at 9:53 AM
Bill Text: PDF Analyses: Healthcare Regulation Subcommittee (Post-Meeting) 6/20/2023 (pdf)
Related Bills (1)
Bill Number Subject Filed By Relationship Last Action and Location Track Bills S 1352 Medicaid Enrollees with Sickle Cell Disease Rouson Compare Last Action: 6/20/2023 Chapter No. 2023-258
Committee Amendments (1)
Amendment Sponsor Filed Last Committee Action Format 722687 - Amendment
Between lines 17 and 18, insert:Skidmore 3/22/2023
11:02 AMAdopted without Objection
3/30/2023PDF Citations - Statutes (1)
Citation Catchline Location in Bill Location In Bill Help 409.91235 Page 1 (pdf)